Aescap
Home
Funds
Aescap Life Sciences Fund
Aescap Genetics Fund
Performance
Sustainability
Biotech
High growth
Takeover premiums
Specialized market
Artificial Intelligence
About us
Investment Team
Strategy
Fund setup
Careers
Invest
How to invest
NextGen
Documents
Cure-Finder
Contact
Information meetings
Login
Fund structure
Fund structure
09.17.2021
Aescap Life Sciences Fund
Aescap Genetics Fund
Performance
Sustainability
Attend our meetings
News
Aescap’s Fusion Pharmaceuticals acquired by AstraZeneca for 97% premium
March 19, 2024
4D Molecular Therapeutics up 85% on good news for patients with macular degeneration
February 6, 2024
Opportunities & threats in biotech
January 23, 2024
This site is protected by reCAPTCHA and the Google
Privacy Policy
and
Terms of Service
apply.